The Korean journal of internal medicine

  • 제30권5호
  • /
  • Pages.593-601
  • /
  • 2015
  • /
  • 1226-3303(pISSN)
  • /
  • 2005-6648(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지
DOI QR코드

DOI QR Code

Can proton pump inhibitors reduce rebleeding following Histoacryl sclerotherapy for gastric variceal hemorrhage?

  • Kim, Ka Rham (Division of Gastroenterology, Department of Internal Medicine, Chonnam National University Medical School) ;
  • Jun, Chung Hwan (Division of Gastroenterology, Department of Internal Medicine, Chonnam National University Medical School) ;
  • Cho, Kyu Man (Division of Gastroenterology, Department of Internal Medicine, Chonnam National University Medical School) ;
  • Wi, Jin Woo (Division of Gastroenterology, Department of Internal Medicine, Chonnam National University Medical School) ;
  • Park, Seon Young (Division of Gastroenterology, Department of Internal Medicine, Chonnam National University Medical School) ;
  • Cho, Sung Bum (Division of Gastroenterology, Department of Internal Medicine, Chonnam National University Medical School) ;
  • Lee, Wan Sik (Division of Gastroenterology, Department of Internal Medicine, Chonnam National University Medical School) ;
  • Park, Chang Hwan (Division of Gastroenterology, Department of Internal Medicine, Chonnam National University Medical School) ;
  • Joo, Young Eun (Division of Gastroenterology, Department of Internal Medicine, Chonnam National University Medical School) ;
  • Kim, Hyun Soo (Division of Gastroenterology, Department of Internal Medicine, Chonnam National University Medical School) ;
  • Choi, Sung Kyu (Division of Gastroenterology, Department of Internal Medicine, Chonnam National University Medical School) ;
  • Rew, Jong Sun (Division of Gastroenterology, Department of Internal Medicine, Chonnam National University Medical School)
  • 투고 : 2014.06.21
  • 심사 : 2014.09.22
  • 발행 : 2015.09.01
⟨ 이전 논문 다음 논문 ⟩

초록

Background/Aims: To evaluate the efficacy of proton pump inhibitors (PPIs) in reducing rebleeding and bleeding-related death rates after endoscopic gastric variceal obliteration (GVO) using N-butyl-2-cyanoacrylate (NBC). Methods: This study enrolled 341 patients who were consecutively diagnosed with and treated for bleeding gastric varices. The patients were divided into PPI and non-PPI groups, and their endoscopic findings, initial hemostasis outcomes, rebleeding and bleeding-related death rates, and treatment-related complications were analyzed. Results: The rate of initial hemostasis was 97.1%. rebleeding occurred in 2.2% of patients within 2 weeks, 3.9% of patients within 4 weeks, 18.9% of patients within 6 months, and 27.6% of patients within 12 months of the GVO procedure. A previous history of variceal bleeding (relative risk [RR], 1.955; 95% confidence interval [CI], 1.263 to 3.028; p = 0.003) and use of PPIs (RR, 0.554; 95% CI, 0.352 to 0.873; p = 0.011) were associated with rebleeding. Child-Pugh class C (RR, 10.914; 95% CI, 4.032 to 29.541; p < 0.001), failure of initial hemostasis (RR, 13.329; 95% CI, 2.795 to 63.556; p = 0.001), and the presence of red-colored concomitant esophageal varices (RR, 4.096; 95% CI, 1.320 to 12.713; p = 0.015) were associated with bleeding-related death. Conclusions: The prophylactic use of PPIs reduces rebleeding after GVO using NBC in patients with gastric variceal hemorrhage. However, prophylactic use of PPIs does not reduce bleeding-related death.

키워드

과제정보

연구 과제 주관 기관 : Chonnam National University Hospital

참고문헌

  1. Sarin SK, Kumar A. Gastric varices: profile, classification, and management. Am J Gastroenterol 1989;84:1244-1249.
  2. Watanabe K, Kimura K, Matsutani S, Ohto M, Okuda K. Portal hemodynamics in patients with gastric varices: a study in 230 patients with esophageal and/or gastric varices using portal vein catheterization. Gastroenterology 1988;95:434-440. https://doi.org/10.1016/0016-5085(88)90501-X
  3. Sarin SK, Lahoti D, Saxena SP, Murthy NS, Makwana UK. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology 1992;16:1343-1349. https://doi.org/10.1002/hep.1840160607
  4. Sarin SK. Long-term follow-up of gastric variceal sclerotherapy: an eleven-year experience. Gastrointest Endosc 1997;46:8-14. https://doi.org/10.1016/S0016-5107(97)70202-5
  5. Garcia-Tsao G, Sanyal AJ, Grace ND, Carey W; Practice Guidelines Committee of the American Association for the Study of Liver Diseases; Practice Parameters Committee of the American College of Gastroenterology. Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis. Hepatology 2007;46:922-938. https://doi.org/10.1002/hep.21907
  6. Huang YH, Yeh HZ, Chen GH, et al. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc 2000;52:160-167. https://doi.org/10.1067/mge.2000.104976
  7. Mumtaz K, Majid S, Shah H, et al. Prevalence of gastric varices and results of sclerotherapy with N-butyl 2 cyanoacrylate for controlling acute gastric variceal bleeding. World J Gastroenterol 2007;13:1247-1251. https://doi.org/10.3748/wjg.v13.i8.1247
  8. Fry LC, Neumann H, Olano C, Malfertheiner P, Monkemuller K. Efficacy, complications and clinical outcomes of endoscopic sclerotherapy with N-butyl-2-cyanoacrylate for bleeding gastric varices. Dig Dis 2008;26:300-303. https://doi.org/10.1159/000177012
  9. Oho K, Iwao T, Sumino M, Toyonaga A, Tanikawa K. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study. Endoscopy 1995;27:349-354. https://doi.org/10.1055/s-2007-1005712
  10. Akahoshi T, Hashizume M, Shimabukuro R, et al. Longterm results of endoscopic Histoacryl injection sclerotherapy for gastric variceal bleeding: a 10-year experience. Surgery 2002;131(1 Suppl):S176-S181. https://doi.org/10.1067/msy.2002.119501
  11. Park WG, Yeh RW, Triadafilopoulos G. Injection therapies for variceal bleeding disorders of the GI tract. Gastrointest Endosc 2008;67:313-323. https://doi.org/10.1016/j.gie.2007.09.052
  12. Kok K, Bond RP, Duncan IC, et al. Distal embolization and local vessel wall ulceration after gastric variceal obliteration with N-butyl-2-cyanoacrylate: a case report and review of the literature. Endoscopy 2004;36:442-446. https://doi.org/10.1055/s-2004-814323
  13. Gimson A, Polson R, Westaby D, Williams R. Omeprazole in the management of intractable esophageal ulceration following injection sclerotherapy. Gastroenterology 1990;99:1829-1831. https://doi.org/10.1016/0016-5085(90)90495-M
  14. Shaheen NJ, Stuart E, Schmitz SM, et al. Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial. Hepatology 2005;41:588-594. https://doi.org/10.1002/hep.20593
  15. Hidaka H, Nakazawa T, Wang G, et al. Long-term administration of PPI reduces treatment failures after esophageal variceal band ligation: a randomized, controlled trial. J Gastroenterol 2012;47:118-126. https://doi.org/10.1007/s00535-011-0472-0
  16. de Franchis R, Baveno VF. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53:762-768. https://doi.org/10.1016/j.jhep.2010.06.004
  17. Hashizume M, Kitano S, Yamaga H, Koyanagi N, Sugimachi K. Endoscopic classification of gastric varices. Gastrointest Endosc 1990;36:276-280. https://doi.org/10.1016/S0016-5107(90)71023-1
  18. Tan PC, Hou MC, Lin HC, et al. A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage: N-butyl-2-cyanoacrylate injection versus band ligation. Hepatology 2006;43:690-697. https://doi.org/10.1002/hep.21145
  19. de Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis 2001;5:645-663. https://doi.org/10.1016/S1089-3261(05)70186-0
  20. Trudeau W, Prindiville T. Endoscopic injection sclerosis in bleeding gastric varices. Gastrointest Endosc 1986;32:264-268. https://doi.org/10.1016/S0016-5107(86)71843-9
  21. Arakawa M, Masuzaki T, Okuda K. Pathomorphology of esophageal and gastric varices. Semin Liver Dis 2002;22:73-82. https://doi.org/10.1055/s-2002-23208
  22. Toriumi DM, Raslan WF, Friedman M, Tardy ME Jr. Variable histotoxicity of histoacryl when used in a subcutaneous site: an experimental study. Laryngoscope 1991;101(4 Pt 1):339-343. https://doi.org/10.1002/lary.1991.101.4.339
  23. Kind R, Guglielmi A, Rodella L, et al. Bucrylate treatment of bleeding gastric varices: 12 years' experience. Endoscopy 2000;32:512-519. https://doi.org/10.1055/s-2000-3817
  24. Kim T, Shijo H, Kokawa H, et al. Risk factors for hemorrhage from gastric fundal varices. Hepatology 1997;25:307-312. https://doi.org/10.1002/hep.510250209

피인용 문헌

  1. Risk factors of in-hospital mortality among patients with upper gastrointestinal bleeding and acute myocardial infarction vol.24, pp.3, 2018, https://doi.org/10.4103/sjg.sjg_492_17
  2. Effects of poor hepatic reserve in cirrhotic patients with bacterial infections: A population-based study vol.32, pp.1, 2020, https://doi.org/10.4103/tcmj.tcmj_142_18